MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

Three days before Trump’s swearing in to office, the US Department of Health and Human Services announced that EcoHealth ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify ...

Reports of a flu-like virus called HMPV in China have sparked online misinformation, including posts with tens of thousands ...

CDC testing data for the same period reveals that 6.6 percent of COVID-19 tests came back positive, with Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin seeing the highest test positivity ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFSThe ...

The following is a summary of “Multiplex lateral flow test sensitivity and specificity in detecting influenza A, B and ...